Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Valneva reports positive Phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001

worldpharmanewsApril 07, 2021

Tag: Valneva , VLA2001 , COVID-19 vaccine

PharmaSources Customer Service